Details

MIPS - Quality Measures - Melanoma: Overutilization of Imaging Studies in Melanoma

Quality Measures
Category QUALITY
Description Percentage of patients, regardless of age, with a current diagnosis of Stage 0 through IIC melanoma or a history of melanoma of any stage, without signs or symptoms suggesting systemic spread, seen for an office visit during the one-year measurement period, for whom no diagnostic imaging studies were ordered
eMeasure ID
First Performance Year 2017
Last Performance Year
Metric Type Single Performance Rate
National Quality Strategy Domain ECR
Measure Type Process
eMeasure UUID
NQF eMeasure ID
NQF ID 0562
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward American Academy of Dermatology
Submission Methods Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_224_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec

Back to List